moxifloxacin has been researched along with Diabetes Mellitus in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angkadjaja, J; Chu, J; Peng, J; Rauser, M; Sierpina, DI | 1 |
| Akkerman, OW; Alffenaar, JC; Bolhuis, MS; de Lange, WCM; Dekkers, BGJ; Ter Beek, L; van der Werf, TS | 1 |
| Haak, T; Kees, F; Kees, MG; Kloft, C; Wicha, SG; Zink, K | 1 |
| Joukhadar, C; Kovar, F; Lackner, E; Minar, E; Müller, M; Müller-Zellenberg, U; Stass, H | 1 |
| Choudhri, S; Gavin, JR; Gross, R; Himmel, H; Kubin, R; Kubitza, D; Meyer, JM | 1 |
5 other study(ies) available for moxifloxacin and Diabetes Mellitus
| Article | Year |
|---|---|
Evaluating the effect of intravitreal triamcinolone-moxifloxacin during cataract surgery on central macular edema in patients with preexisting diabetic retinopathy.
Topics: Cataract; Diabetes Mellitus; Diabetic Retinopathy; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Moxifloxacin; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide | 2020 |
Reduced moxifloxacin exposure in patients with tuberculosis and diabetes.
Topics: Adult; Antitubercular Agents; Comorbidity; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Moxifloxacin; Tuberculosis | 2019 |
Population pharmacokinetics and target attainment analysis of moxifloxacin in patients with diabetic foot infections.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Diabetes Mellitus; Diabetic Foot; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Middle Aged; Monte Carlo Method; Moxifloxacin | 2015 |
Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans.
Topics: Adipose Tissue; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Aza Compounds; Diabetes Complications; Diabetes Mellitus; Female; Fluoroquinolones; Humans; Male; Microdialysis; Middle Aged; Moxifloxacin; Quinolines; Soft Tissue Infections; Tissue Distribution | 2003 |
Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Blood Glucose; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diabetes Mellitus; Fluoroquinolones; Glucose; Homeostasis; Humans; Hyperglycemia; Hypoglycemia; Male; Moxifloxacin; Product Surveillance, Postmarketing; Quinolines; Rats | 2004 |